SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001047469-13-000481
Filing Date
2013-01-28
Accepted
2013-01-28 16:17:51
Documents
8
Period of Report
2013-01-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2212593z8-k.htm 8-K 28028
2 EX-99.1 a2212593zex-99_1.htm EX-99.1 430514
  Complete submission text file 0001047469-13-000481.txt   6449628

Data Files

Seq Description Document Type Size
3 EX-101.INS bpax-20130128.xml EX-101.INS 715662
4 EX-101.SCH bpax-20130128.xsd EX-101.SCH 67041
5 EX-101.DEF bpax-20130128_def.xml EX-101.DEF 398810
6 EX-101.LAB bpax-20130128_lab.xml EX-101.LAB 1037603
7 EX-101.CAL bpax-20130128_cal.xml EX-101.CAL 67100
8 EX-101.PRE bpax-20130128_pre.xml EX-101.PRE 518741
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 13551912
SIC: 2836 Biological Products, (No Diagnostic Substances)